Published • loading... • Updated
TELA Bio Plans Board Overhaul, Reports Preliminary Q1 Revenue Beat
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
TELA Bio Plans Board Overhaul, Reports Preliminary Q1 Revenue Beat
MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA) said it will replace four of its seven directors following its June 9 annual meeting and reported preliminary first-quarter revenue above prior guidance, as the company reshapes its board and advances its commercial operations. The company announced that Chairman Doug Evans, along with directors Kurt Azarbarzin, Vince Burgess and Federica O’Brien, will step down at the conclusion of the meeting, with f…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
